Skip to main content

Table 14 Benchmarking of device-associated healthcare-acquired infection rates in this report against the report of the International Nosocomial Infection Control Consortium (2007–20012) and the report of the US National Healthcare Safety Network Data (2011)

From: International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003–2012

 

This report

INICC report (2007–2012) [ [10]]

U.S. NHSN report (2011) [ [5]]

Medical surgical ICU

   

CL, DUR

0.65 (0.65 – 0.65)

0.54 (0.54 – 0.54)

0.35 (0.35 – 0.35)

CLABSI rate

8.5 (8.0 – 9.1)

4.9 (4.8 – 5.1)

0.9 (0.8 - 0.9)

MV, DUR

0.54 (0.54 – 0.54)

0.36 (0.36 – 0.36)

0.24 (0.24 – 0.24)

VAP rate

22.3 (21.3 - 23.2)

16.5 (16.1 – 16.8)

1.1 (9.8 - 1.2)

UC, DUR

0.88 (0.88 – 0.88)

0.62 (0.62 – 0.62)

0.54 (0.54 – 0.54)

CAUTI rate

7.9 (7.5 - 8.4)

5.3 (5.2 – 5.8)

1.2 (1.1 - 1.3)

Paediatric ICU

   

CL, DUR

0.40 (0.40 – 0.41)

0.50 (0.50 – 0.50)

0.47 (0.46 – 0.47)

CLABSI rate

9.5 (7.9 – 11.3)

6.1 (5.7 – 6.5)

1.8 (1.6 - 1.9)

MV, DUR

0.53 (0.53 – 0.54)

0.53 (0.53 – 0.53)

0.40 (0.40 – 0.40)

VAP rate

11.7 (10.2 - 13.5)

7.9 (7.4 – 8.4)

1.1 (9.0 - 1.2)

UC, DUR

0.34 (0.34 – 0.35)

0.31 (0.31 – 0.32)

0.23 (0.22 – 0.23)

CAUTI rate

6.6 (5.2 - 8.4)

5.6 (5.1 – 6.1)

3.1 (2.7 - 3.5)

Neonatal ICU (weight 1501 to 2500 grams)

   

CL, DUR

0.09 (0.09 – 0.10)

0.21 (0.20 – 0.21)

0.18 (0.18 – 0.19)

CLABSI rate

7.8 (3.4 – 15.4)

4.8 (3.7 – 6.1)

0.7 (0.6 - 0.9)

MV, DUR

0.12 (0.11 – 0.13)

0.10 (0.10 – 0.11)

0.07 (0.07 – 0.07)

VAP rate

14.4 (8.7 - 22.5)

10.7 (8.4 – 13.4)

0.5 (0.2 - 0.9)

  1. ICU, intensive care unit; CLABSI, central line-associated bloodstream infection; VAP, ventilator-associated pneumonia; CAUTI, catheter-associated urinary tract infection; DUR, device use ratio; INICC, International Nosocomial Infection Control Consortium; U.S. NSHN, National Healthcare Safety Network of the United States of America.